Skip to main content
. 2020 Jul 14;8:298. doi: 10.3389/fpubh.2020.00298

Table 8.

Relevance of barriers to PrEP use.

n M (SD) Min-Max
Worries about getting infected with other STIs 111 5.56 (2.73) 0-10
The monthly costs for the PrEP medication 109 5.33 (2.61) 0-10
Lack of information about PrEP in the native language of the client 110 5.10 (3.33) 0-10
The costs for the laboratory investigations 109 4.80 (3.00) 0-10
Worries about mild or temporary side effects 109 4.64 (2.43) 0-10
Time required for regular visits to the doctor 111 4.26 (2.81) 0-10
Worries about severe or permanent side effects 111 4.21 (2.59) 0-10
Lack of information about PrEP in client-friendly language 110 4.17 (2.88) 0-10
Difficulties finding a doctor who prescribes PrEP 112 4.13 (3.64) 0-10
Assessment of the own risk of getting infected with HIV as too low to take PrEP 110 4.08 (2.70) 0-10
Worries about stigmatization in the peer group 107 3.33 (2.67) 0-10
Cultural barriers 110 2.79 (2.51) 0-10

M, mean; Max, maximum; Min, minimum; SD, standard deviation.